CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
August 2022—Beckman Coulter and Scopio Labs announced a worldwide partnership to accelerate the adoption of Scopio’s next-generation peripheral blood smear platforms. Scopio’s technology uses full-field imaging and AI decision support to eliminate manual microscopy.
“By leveraging computational photography, Scopio generates a high-resolution, full-field image of the sample, including a large scan area and the smallest details. This is a leap in digital morphology capabilities, and with easy and secure remote viewing, can help laboratories significantly reduce manual labor burden while improving turnaround time,” Peter Soltani, PhD, senior vice president and general manager at Beckman Coulter, said in a press statement. “We are excited to partner with Scopio Labs to bring cutting-edge digital peripheral blood smear analysis and the use of AI decision support to our customers, continuing our push to innovate and solve everyday problems for the lab.”